Crossmark

Integrated single-cell and machine learning analysis identifies PMAIP1 as a novel biomarker for predicting prognosis and immunotherapy response in colorectal cancer

Crossref DOI link: https://doi.org/10.1038/s41598-025-32933-8

Published Online: 2025-12-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Xiangfang

Cai, Zihan

Ding, Shoupeng

Gao, Jinghua

Wang, Yuanlin

Wu, Yuqian

Zhang, Huangyan

Chen, Jiachuan

Hu, Zongqiang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82360529)
License Information

Text and Data Mining valid from 2025-12-23

Version of Record valid from 2026-01-28
More Information

Article History

Received: 22 October 2025

Accepted: 15 December 2025

First Online: 23 December 2025

Declarations

:

: The authors declare no competing interests.

: This study has been approved by the Research Ethics Committee of Chuxiong Prefecture People’s Hospital(KYLL-2025010).

Document is current

Any future updates will be listed below